Embedded Files
Next Generation Sequencing Market Report
The global next generation sequencing market size was accounted for USD 13.08 billion in 2024 and is expected to be worth around USD 47.10 billion by 2034, growing at a compound annual growth rate (CAGR) of 13.66% from 2025 to 2034.
The market research report on the Next Generation Sequencing Market industry provides crucial insights into current growth trends and primary revenue drivers from 2025 to 2034. It explores various elements impacting the Next Generation Sequencing Market, offering a thorough understanding of its dynamics. This report acts as a strategic tool for achieving business goals, featuring the latest market scenarios and significant innovations within the industry.
Achieving market dominance and establishing a robust presence in any sector often relies on comprehensive market research. The Next Generation Sequencing Market report utilizes tables, charts, and graphs to present data clearly, enhancing comprehension. It underscores key market trends and discussions, assisting clients in evaluating competitive landscapes. Furthermore, the report includes essential market information such as definitions, classifications, significant developments, applications, and engagements. By employing various visual aids tailored to the depth of content, the Next Generation Sequencing Market survey report delivers a holistic overview of the industry landscape.
Next Generation Sequencing Market Report Highlights
North America has accounted highest revenue share of 49.4% in 2024.
Europe has generated revenue share of 25.45% in 2024.
By end use, academic research institutions segment has captured 34.71% revenue share in 2024.
By product, consumables segment has calculated highest revenue share of 57% in 2024.
Get a Sample PDF of the Report: https://www.cervicornconsulting.com/sample/2317
Next Generation Sequencing Market Trends
Decreasing Cost of Sequencing: The cost of sequencing has significantly decreased over the years due to technological advancements and economies of scale. This reduction has made NGS more affordable for research institutions, clinical laboratories, and other end users.
Integration with Artificial Intelligence and Machine Learning: The integration of artificial intelligence (AI) and machine learning (ML) with NGS data analysis is enhancing the speed and accuracy of genomic interpretations. AI-driven tools help in analyzing vast amounts of genomic data, identifying patterns, and predicting disease outcomes.
Growing Prevalence of Genetic Disorders: The increasing prevalence of genetic disorders and rare diseases is driving the demand for advanced diagnostic tools like NGS. NGS offers comprehensive genetic analysis, enabling the identification of disease-causing mutations and guiding therapeutic interventions.
Expansion in Emerging Markets: Emerging markets present significant opportunities for NGS adoption due to rising healthcare infrastructure development, increasing research activities, and growing awareness of precision medicine. As these regions invest in healthcare advancements, there is an increasing demand for cost-effective and high-throughput sequencing solutions.
Development of Point-of-Care Sequencing Solutions: The development of point-of-care (POC) sequencing solutions represents a major opportunity for the NGS market. POC devices can provide rapid and accurate genomic analysis at the patient’s location, enabling immediate clinical decision-making.
Next Generation Sequencing Market Growth Factors
Rising Demand for Personalized Medicine: The growing focus on personalized medicine is a major driver for the NGS market. By enabling precise genetic profiling, NGS facilitates the development of tailored treatment plans based on an individual’s genetic makeup. This approach improves treatment efficacy and reduces adverse effects, leading to increased adoption in clinical settings.
Technological Advancements in Sequencing Technologies: Continuous advancements in sequencing technologies have led to faster, more accurate, and cost-effective NGS solutions. Innovations such as improved sequencing platforms, enhanced bioinformatics tools, and automation have reduced the time and cost associated with genomic analysis.
Increasing Applications in Clinical Diagnostics: NGS is increasingly being used in clinical diagnostics for various applications, including cancer diagnostics, prenatal testing, and infectious disease detection. The ability of NGS to provide comprehensive genomic insights enables early disease detection, accurate diagnosis, and monitoring of treatment responses.
Government and Private Funding for Genomic Research: Substantial funding from governments and private organizations for genomic research and precision medicine initiatives is propelling the NGS market. Initiatives like the Human Genome Project and national genomics programs have accelerated advancements in sequencing technologies.
Expansion of NGS in Agricultural and Animal Research: NGS is playing an increasingly important role in agriculture and animal research by enabling the study of genetic traits, disease resistance, and crop improvement. The technology helps in understanding genetic variations in plants and animals, facilitating breeding programs and improving yield and quality.
Key Players in the Next Generation Sequencing Market
Illumina, Inc.
Thermo Fisher Scientific Inc.
Pacific Biosciences of California, Inc.
Oxford Nanopore Technologies Limited
Genomatix Software GmbH
QIAGEN N.V.
BGI Genomics Co., Ltd.
Roche Holding AG
Agilent Technologies, Inc.
Guardant Health, Inc.
Nimble Genomics Inc.
Rhapsody Biosciences, Inc.
10x Genomics, Inc.
Molecular Devices, LLC
Beckman Coulter, Inc.
The report provides a detailed analysis of key players in the global Next Generation Sequencing Market, highlighting their strategic initiatives. These players have adopted various strategies, including new product launches, partnerships, expansions, joint ventures, and agreements, to strengthen their market presence and maintain leadership positions across different regions. The report offers valuable insights into business performance, operational segments, product portfolios, and strategic actions, effectively illustrating the competitive environment within the industry.
Next Generation Sequencing Market Segmentation
By Product Type
Sequencing Platforms
Sequencers
Software
Consumables
Reagents and Kits
Others
Services
Sequencing Services
Bioinformatics Services
By Technology
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing & Resequencing
RNA-Seq
DNA-Seq
Others
By Application
Clinical Applications
Oncology
Reproductive Health
Rare Diseases
Infectious Diseases
Research Applications
Drug Discovery
Genetic Research
Agriculture and Animal Research
Reproductive Health
NIPT
PGT
Newborn Genetic Screening
Single Gene Analysis
HLA Typing/Immune System Monitoring
Metagenomics, Epidemiology & Drug Development
Agrigenomics & Forensics
Consumer Genomics
By Workflow
Pre-Sequencing
NGS Library Preparation Kits
Semi-automated Library Preparation
Automated Library Preparation
Sequencing
NGS Data Analysis
NGS Primary Data Analysis
NGS Secondary Data Analysis
By End User
Academic Research Institutions
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Clinical Research Organizations
Regional Analysis of the Next Generation Sequencing Market:
North America (United States, Canada, Mexico)
Europe (Germany, France, UK, Russia, Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
Request For Customization: https://www.cervicornconsulting.com/customization/2317
Report Highlights
Market Expansion: In-depth insights into the product offerings of key players in the Next Generation Sequencing Market, providing a comprehensive overview of their portfolios.
Competitive Analysis: A thorough examination of market strategies, geographic presence, and business segments of leading industry players, enhancing understanding of competitive positioning.
Market Development: Detailed analysis of emerging markets, with insights into various segments across geographical regions, supporting informed decision-making.
Market Diversification: Extensive coverage of new products, untapped regions, recent developments, and investments in the Next Generation Sequencing Market, offering valuable insights into opportunities for growth and expansion.
The conclusion of the Next Generation Sequencing Market report presents an analysis of investment opportunities and developmental trends, providing insights into both current and future prospects within the rapidly evolving international industry segments. Additionally, the report details product specifications, manufacturing processes, cost structures, and pricing strategies, delivering a comprehensive overview of the market landscape.
Purchase the Report: (Available for 3800 USD for a single-region license)- https://www.cervicornconsulting.com/buy-now/2317
About Us: Cervicorn Consulting specializes in providing expert analysis and accurate market intelligence, helping companies of all sizes make well-informed decisions.
Contact Us:
Phone: +91 7499931916
Email: sales@cervicornconsulting.com
Web:https://www.cervicornconsulting.com/
Top Trending Report List:
Point of Care Diagnostics Market
Asset Lifecycle Management Market
Page updated
Google Sites
Report abuse